BioAge Labs (BIOA) Times Interest Earned (2023 - 2026)
BioAge Labs (BIOA) reported Times Interest Earned of -$253.75 for Q1 2026, down 362.88% on a YoY basis from $96.53 in Q1 2025, and up 17.87% sequentially from -$308.95 in Q4 2025.
BioAge Labs (BIOA) Times Interest Earned (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Times Interest Earned data on file, last reported at -$253.75 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 362.88% year-over-year to -$253.75; the trailing twelve-month figure through Mar 2026 stood at -$125.41 (down 249.29% YoY), and the FY2025 full-year result was -$2.01, up 93.93% from the prior year.
- Times Interest Earned improved to -$253.75 in Q1 2026, from -$308.95 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.42 in Q3 2024 to a low of -$308.95 in Q4 2025.
- A 4-year average of -$71.29 and a median of -$31.52 in 2025 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 89.89% in 2024, while the deepest fall reached 4055.93% in 2024.
- Tracing BIOA's Times Interest Earned over 4 years: stood at -$1.91 in 2023, then plunged by 4055.93% to -$79.5 in 2024, then sank by 288.59% to -$308.95 in 2025, then climbed by 17.87% to -$253.75 in 2026.
- Business Quant data shows BIOA's Times Interest Earned at -$253.75 in Q1 2026, -$308.95 in Q4 2025, and -$4.22 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | -253.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253.75 |
| Dec 31, 2025 | -308.95 |
| Sep 30, 2025 | -4.22 |
| Jun 30, 2025 | -31.52 |
| Mar 31, 2025 | -54.82 |
| Dec 31, 2024 | -79.50 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -34.47 |
| Mar 31, 2024 | -10.53 |
| Dec 31, 2023 | -1.91 |
| Sep 30, 2023 | -4.11 |